
Venture capital
TCG Labs
TCG Labs Soleil is a venture-biotech platform pairing a venture fund with an evergreen R&D hub in South San Francisco, working alongside The Column Group. It forms single-asset therapeutics companies.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is TCG Labs right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds TCG Labs joined, from press and the firm’s own posts.
Every round TCG Labs joined
Round sizes, TCG Labs’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company TCG Labs backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet TCG Labs
Events where TCG Labs’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
TCG Labs is based in San Francisco, United States. It also has offices in South San Francisco and Shanghai.
2 fund vehicles are on public registers (SEC adviser filings), including TCG LABS OPPORTUNITY I, LP and TCG LABS FUND I, LP.
The firm builds independent portfolio companies, each centred on one therapeutic asset, and takes them from idea to human proof of concept. The goal is to prepare de-risked assets for strategic transactions and late-stage development by pharma partners, using dedicated capital and an in-house drug discovery team. From the firm’s own website.
TCG Labs lists 1 portfolio company on its website: Juri Biosciences.
Know before TCG Labs’s next round is announced.
PRO tracks TCG Labs’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.